Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation
Recruiting
N/A
Interventional Study
Lens Implantation, Intraocular
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 Months – 14
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 228 (estimated)
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To compare the incidence of glaucoma-related adverse events of in-the-bag versus ciliary-sulcus-fixed secondary intraocular lens (IOL) implantation in pediatric aphakia
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged between 18 months and 14 years
* Had a primary diagnosis of congenital cataract.
* Underwent cataract extraction between the ages of 2 and 24 months
Exclusion Criteria:
* Primary IOL implantation
* Pre-existing ocular disease which might affect the location and outcome …
Contacts